Please provide your email address to receive an email when new articles are posted on . The Vivatmo me measures and records fractional exhaled nitric oxide, symptoms and medication use at home. 80.7% ...

Women experience more frequent asthma attacks, and prior attack history is a statistically stronger predictor of future events in men.

This case study has been carried out by Carol Stonham MBE, a Medical Advisory Board member. Carol has worked as a registered nurse since 1986, shifting from acute hospital care to primary care by 1990 ...

Please provide your email address to receive an email when new articles are posted on . High FeNO levels indicate exacerbation and lung function risks. Most patients with high FeNO levels also had ...

As the world prepares to observe World Health Day on April 7 th, 2025, Bedfont ® Scientific Limited highlights the importance of early and accurate asthma diagnosis with its innovative NObreath ® ...

Respiratory specialist nurse Maria Eurton discusses case examples to explain how to approach common diagnostic challenges in adult asthma ...

Bronchi during asthma attack Dupilumab significantly reduced severe asthma exacerbations and improved prebronchodilator FEV1 in patients with baseline FeNO greater than or equal to 25 ppb with/without ...

Nov. 17, 2021 – In its latest clinical practice guideline on evaluation and treatment of asthma, an American Thoracic Society expert guidelines panel has addressed the use of fractional exhaled nitric ...

IS LUNG HEALTH DAY, THOUGH MANY OF US TAKE BREATHING FOR GRANTED, MILLIONS OF PEOPLE STRUGGLE GETTING ENOUGH AIR DUE TO ASTHMA CONDITION THAT CAN BE DEADLY. AN ESTIMATED 262 MILLION PEOPLE WORLDWIDE ...

MORRISVILLE, N.C.--(BUSINESS WIRE)--Circassia Inc. announced today that it has successfully engaged with major primary care national sales partners to expand the distribution of NIOX VERO®, its FeNO ...

Blood eosinophil count and fractional exhaled nitric oxide (FeNO) play an important role in selecting biological therapies for severe asthma. This analysis of patient-level data pooled across 22 ...

Multiple doses of APG808 resulted in rapid suppression of FeNO, a biomarker of Type 2 inflammation associated with exacerbations in asthma, with a robust maximal FeNO decrease from baseline of 53% ...